Emerging evidence suggests that treatment with the dual GLP-1 and GIP receptor agonist, tirzepatide, might prove even more potent than a GLP-1RA alone, to ameliorate NAFLD
This guide covers the clinical landscape of compounded dermatology medicationscommon formulations, quality considerations, and how digital prescribing tools are making dermatology compounding more accessible
Concentrated solutions (10 mg/mL) require smaller injection volumes, which can be challenging to measure accurately with standard syringes
Ausencia de efectos secundarios mayores en los estudios: Dato destacable: las publicaciones sobre el BPC-157 no reportan prcticamente ningn efecto adverso en los modelos animales estudiados
Implementation of GLP-1 RA-specific medical nutrition therapy protocols, with dietitian involvement to optimize dietary recommendations and manage adverse events, is recommended